三唑类抗真菌药泊沙康唑的临床应用
摘要
泊沙康唑(posaconazole)是新型三唑类抗真菌药,对霉菌和酵母菌具有广谱抗菌活性,且抗菌作用强,对难治性或侵袭性真菌感染有效。本文综述其抗真菌机制、药动学、体内外试验、临床研究、用法用量及药物相互作用。
出处
《世界临床药物》
CAS
2005年第12期754-756,759,共4页
World Clinical Drug
参考文献10
-
1Munayyer HK,Mann PA,Chau AS,et al.Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds[].Antimicrobial Agents and Chemotherapy.2004
-
2Courtney R,Sansone A,Smith W,et al.Posaconazole Pharmacokinetics, safety and tolerability in subjects with varying degrees of chronic renal disease[].Journal of Clinical Pharmacology.2005
-
3Tobon AM,Correa AL,Arango M,et al.Posaconazole therapy for severe abdominal candidiasis: a case report[].Revista Iberoamericana de Micologia.2004
-
4Herbrecht R.Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections[].International Journal of Clinical Practice.2004
-
5Courtney R,Wexler D,Radwanski E,et al.Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults[].British Journal of Clinical Pharmacology.2004
-
6Courtney R,Radwanski E,Lim J,et al.Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men[].Antimicrobial Agents and Chemotherapy.2004
-
7Courtney R,Pai S,Laughlin M,et al.Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults[].Antimicrobial Agents and Chemotherapy.2003
-
8Yildiran ST,Fothergill AW,Sutton DA,et al.In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole, voriconazole and posaconazole (SCH56592)[].Mycoses.2002
-
9Barchiesi F,Schimizzi AM,Najvar LK,et al.Interactions of posaconazole and flucytosine against Cryptococcus neoformans[].Antimicrobial Agents and Chemotherapy.2001
-
10Herbrecht R,Kessler R,Kravanja C,et al.Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient[].The Journal of Heart and Lung Transplantation.2004
-
1谢芳.FDA接受posaconazole的NDA[J].国外药讯,2004(9):23-23.
-
2伍晓群,李健和,熊友健,徐幸民.泊沙康唑的药动学及其药物相互作用[J].中国新药与临床杂志,2011,30(5):380-384. 被引量：5
-
3夏路风,刘蕾,傅得兴.新型广谱三唑类抗真菌药泊沙康唑[J].中国新药杂志,2007,16(15):1226-1231. 被引量：9
-
4李可欣,胡欣,孙春华,万翼英.茶碱缓释片体内外试验相关性的研究[J].中国药学杂志,1991,26(12):728-731. 被引量：6
-
5王锐,李可欣,孙春华,傅得兴,游天童.氟罗沙星的体内外试验相关性研究[J].中国药房,1995,6(1):25-26. 被引量：4
-
6赵晓岚,谢裕南,朱慧兰.左西替利嗪和西替利嗪中枢神经系统抑制作用的临床观察[J].中国麻风皮肤病杂志,2007,23(9):807-807. 被引量：2
-
7吴小林.Posaconazole:新的有效用于严重疾病的抗真菌药[J].国外医药（抗生素分册）,2004,25(3):144-144.
-
8张娟,廖银根.伏立康唑的抗真菌机制与治疗药物监测进展[J].中国药房,2012,23(14):1322-1324. 被引量：31
-
9杨宏图,常翠,宁德俄,徐群英,毕殿洲.奈福泮缓释胶囊体内外试验的相关性研究[J].药学实践杂志,2003,21(1):20-23.
-
10丁丽远,黄松春.氟康唑在眼科临床上的应用[J].国外医学（眼科学分册）,1994,18(5):262-266. 被引量：29
